U.S. Residential REITs Stock News

NYSE:DD
NYSE:DDChemicals

Is DuPont De Nemours (DD) Still Attractively Priced After Its Strong One Year Share Price Run?

If you are wondering whether DuPont de Nemours shares still offer value at around US$51.07, it helps to step back and look at what the current price might be implying about the business. The stock has returned 0.4% over the last 7 days, 15.7% over the past month, 25.0% year to date and 52.3% over the past year, with longer term returns of 76.8% over 3 years and 83.4% over 5 years. Recent news around DuPont has focused on the company's portfolio positioning and its place in the broader...
NasdaqGS:DPZ
NasdaqGS:DPZHospitality

Domino’s Pizza (DPZ) Margin Holds At 12.2% Challenging Profitability Bear Narratives

Domino’s Pizza (DPZ) has wrapped up FY 2025 with fourth quarter revenue of US$1.5b and basic EPS of US$5.35, setting the tone for a year where trailing twelve month revenue came in at about US$4.9b and EPS reached US$17.69. Over recent quarters, revenue has ranged from US$1.1b to US$1.5b while quarterly EPS has moved between roughly US$3.84 and US$5.35. This gives investors a clear read on how sales and earnings are tracking into the current share price of US$414.20. With trailing net margins...
NYSE:LAZ
NYSE:LAZCapital Markets

New Healthcare Hires And Margin Pressure Might Change The Case For Investing In Lazard (LAZ)

In February 2026, Lazard, Inc. added John Koski and Rob Lowe as Managing Directors in its New York Healthcare Group, bringing experience across payors, providers, distributors, and healthcare–technology transactions from roles at Allen & Co. and Citi. Around the same time, Lazard reported quarterly results with revenue growth but pressure on margins and earnings, prompting investors to weigh expansion efforts against profitability trends and insider share sales. Next, we’ll examine how...
NasdaqGS:PCAR
NasdaqGS:PCARMachinery

Is It Time To Reassess PACCAR (PCAR) After Strong Multi Year Share Price Gains?

If you are wondering whether PACCAR's current share price reflects its underlying worth, this article walks through the key numbers that matter for valuation. PACCAR's stock recently closed at US$126.25, with returns of 3.5% over the past 30 days, 13.2% year to date, and 21.5% over the last year. The 7 day return sits at a 0.2% decline and the 3 year and 5 year returns are 95.3% and 142.0% respectively. Recent news around PACCAR has focused on its position as a major commercial vehicle...
NYSE:AORT
NYSE:AORTMedical Equipment

Artivion (AORT) Valuation Check After Return To Profit And Higher Full Year Revenue

Artivion (AORT) is back in focus after reporting fourth quarter and full year 2025 earnings, with revenue of US$115.99 million for the quarter and US$441.33 million for the year, as well as a move to positive net income. See our latest analysis for Artivion. Despite the move to profitability, Artivion’s 1 month share price return of a 17.83% decline and 90 day share price return of a 24.03% decline suggest recent momentum has cooled. However, the 1 year total shareholder return of 38.30% and...
NasdaqGS:LULU
NasdaqGS:LULULuxury

How Investors Are Reacting To Lululemon (LULU) Using Franchises To Drive International Store Expansion

lululemon athletica has marked a milestone in its international expansion with the opening of its 100th EMEA store in Warsaw, Poland on March 13, its first location in the country and part of a mix of company-operated and franchise stores across the region. This store, opened through a franchise partnership with Arion Retail Group and alongside plans to enter Hungary, Romania, Greece, India, and Austria, highlights how lululemon is leaning on capital-light partnerships to broaden its...
NYSE:PK
NYSE:PKHotel and Resort REITs

A Look At Park Hotels & Resorts (PK) Valuation After Results, Guidance, Dividend Update And New COO Appointment

Park Hotels & Resorts (PK) shares are back in focus after the company reported fourth quarter and full year 2025 results, paired with fresh 2026 guidance, a leadership change, and a reaffirmed cash dividend. See our latest analysis for Park Hotels & Resorts. The latest results, dividend affirmation and the appointment of Sean Dell’Orto as COO come as Park Hotels & Resorts trades near US$11.27, with a 90 day share price return of 4.06% and a 3 year total shareholder return of 13.70%. This...
NasdaqGS:KDP
NasdaqGS:KDPBeverage

Keurig Dr Pepper (KDP) Margins Improve To 12.5% Net Profit Challenging Coffee Weakness Concerns

Keurig Dr Pepper (KDP) has wrapped up FY 2025 with fourth quarter revenue of US$4.5 billion and basic EPS of US$0.26, setting the tone for how investors assess the full year. The company has seen quarterly revenue move from US$4.1 billion in Q4 2024 to US$4.5 billion in Q4 2025, while quarterly EPS shifted from a loss of US$0.11 to EPS of US$0.26 over the same period, against a trailing twelve month EPS of US$1.53. With trailing net margin at 12.5% and earnings growth highlighted over the...
NYSE:KO
NYSE:KOBeverage

Is Coca-Cola (KO) Priced Fairly After Strong Multi Year Share Price Performance

If you are wondering whether Coca-Cola's share price still lines up with its underlying value, you are not alone. That is exactly what this article aims to unpack. Coca-Cola's stock last closed at US$80.72, with reported returns of 1.5% over 7 days, 10.8% over 30 days, 16.8% year to date and 16.2% over 1 year, as well as 48.4% over 3 years and 87.3% over 5 years. Recent coverage around Coca-Cola has focused on its position as a global consumer staples brand and how investors treat it as a...
NYSE:MAS
NYSE:MASBuilding

Masco Weighs Growth Options As Plumbing And Behr Brands Hold Steady

Masco (NYSE:MAS) is working through a period of flat organic revenue and earnings growth while leaning more heavily on its plumbing and decorative brands. The company is focusing on core products such as Behr paint and plumbing fixtures, which are tied to ongoing home renovation activity. Management attention is turning to potential acquisitions or business adjustments to reaccelerate overall expansion. For you as an investor, the story around Masco (NYSE:MAS) right now is less about...
NasdaqGS:DPZ
NasdaqGS:DPZHospitality

Domino’s Longtime Director Retirement Puts Capital Allocation In Focus

Domino's Pizza (NasdaqGS:DPZ) announced the retirement of longtime board director James A. Goldman. Goldman is stepping down after more than 15 years of service on the company's Board of Directors. His departure marks a change in Domino's corporate governance and board composition. Domino's Pizza, traded on the NasdaqGS under the ticker DPZ, is a global pizza delivery and carryout chain that depends heavily on brand consistency, franchise relationships and technology for ordering and...
NYSE:PRKS
NYSE:PRKSHospitality

Will Earnings After Attendance Slump And Buybacks Change United Parks & Resorts' (PRKS) Narrative

In recent months, United Parks & Resorts has faced weaker attendance and revenue pressure, while authorizing a US$500 million share repurchase program and preparing to report quarterly earnings after a prior revenue miss. Investor focus has intensified after Breach Inlet Capital Management exited its US$13.65 million position, highlighting questions about how buybacks and operational changes might counter ongoing demand and pricing challenges. We’ll now examine how the upcoming earnings...
NYSE:ATEN
NYSE:ATENSoftware

A Look At A10 Networks (ATEN) Valuation After Analyst Upgrades And AI Security Growth Outlook

Recent analyst reports on A10 Networks (ATEN) have spotlighted higher earnings estimates and a firm consensus view, with management tying its growth targets to demand for AI related security and networking infrastructure. See our latest analysis for A10 Networks. At a share price of US$18.99, A10 Networks has seen an 11.8% 90 day share price return and a 9.3% 30 day share price return, while the 1 year total shareholder return of a 4.4% decline contrasts with a 5 year total shareholder return...
NYSE:OC
NYSE:OCBuilding

Owens Corning (OC) Valuation Check After Recent Share Price Weakness

Owens Corning overview after recent performance shifts Owens Corning (OC) has drawn fresh attention after recent share price moves, with a 1 day return of 2.12% decline and a 5.19% decline over the past week prompting investors to reassess the stock. Those short term moves contrast with a 1.80% gain over the past month and a 13.51% return in the past 3 months, alongside a 10.93% return year to date and a 18.58% decline over the past year. See our latest analysis for Owens Corning. For Owens...
NYSE:BOX
NYSE:BOXSoftware

Is Box (BOX) Starting To Look Attractive After A 31% Share Price Slide?

Investors may be wondering if Box is starting to look like a value opportunity after a rough patch, or if the market is rightly cautious about the stock at around US$22.82. The share price has been under pressure, with a 0.6% move over the last week, a 13.8% decline over 30 days, a 20.8% decline year to date, and a 31.1% decline over the past year. However, the 5 year return sits at 21.7%. Recent coverage around Box has focused on its position as a listed software player and how investors...
NasdaqGS:THRM
NasdaqGS:THRMAuto Components

Why Gentherm (THRM) Is Up 8.5% After Soft Q4 Profit But Strong 2026–2027 Revenue Outlook

In February 2026, Gentherm reported fourth‑quarter 2025 earnings showing net income falling to US$2.99 million from US$15.32 million a year earlier, while quarterly revenue of about US$382.79 million came in ahead of expectations. Alongside weaker profitability, Gentherm issued product revenue guidance of US$1.5 billion to US$1.6 billion for 2026 and US$1.7 billion for 2027, highlighting its ambition to grow beyond automotive into medical and other precision thermal applications. We’ll now...
NYSE:WWW
NYSE:WWWLuxury

Is Wolverine World Wide (WWW) Pricing Lagging Its Recent Share Price Recovery

If you are wondering whether Wolverine World Wide at around US$17.58 is offering real value or just looks cheap on the surface, you are not alone. The stock has pulled back over the short term, with a 2.9% decline over 7 days and a 2.4% decline over 30 days, yet it still shows a 19.7% return over 1 year and 14.4% over 3 years, compared with a 42.3% decline over 5 years. Recent attention on Wolverine World Wide has focused on its long term share price pattern. The stronger 1 year and 3 year...
NYSE:DOCN
NYSE:DOCNIT

DigitalOcean Holdings DOCN One Off Gain Lifts Margins And Tests Bullish Narratives

DigitalOcean Holdings FY 2025 Earnings Snapshot DigitalOcean Holdings (DOCN) has wrapped up FY 2025 with Q4 revenue of US$242.4 million and basic EPS of US$0.28, capping off a year in which trailing twelve month revenue reached US$901.4 million and EPS came in at US$2.83. The company has seen revenue move from US$780.6 million to US$901.4 million on a trailing twelve month basis, while EPS shifted from US$0.92 to US$2.83, with reported earnings growth helped by a very large year over year...
NasdaqCM:NEO
NasdaqCM:NEOHealthcare

Is NeoGenomics’ (NEO) RaDaR ST Medicare Win Quietly Redefining Its Oncology Diagnostics Edge?

Earlier in February 2026, NeoGenomics launched RaDaR ST, a high-sensitivity circulating tumor DNA assay for molecular residual disease detection, supported by Medicare approval for initial indications and backed by clinical and real-world data across select cancers. The company also introduced PanTracer Pro to streamline complex molecular testing workflows and reported higher quarterly sales with a smaller net loss, highlighting growing adoption of newer, higher-value oncology...
NYSE:IEX
NYSE:IEXMachinery

Assessing IDEX (IEX) Valuation After Recent Share Price Momentum And Mott Acquisition Integration

Why IDEX (IEX) is on investors’ radar today IDEX (IEX) is drawing attention after a period of steady share price movement, with recent returns and current valuation metrics prompting investors to reassess how the company’s fundamentals line up with its current price. See our latest analysis for IDEX. At a share price of $208.45, IDEX has seen steady momentum recently, with a 30-day share price return of 6.75% and a 90-day share price return of 19.96%. The 1-year total shareholder return of...
NasdaqGS:BRKR
NasdaqGS:BRKRLife Sciences

Is Bruker (BRKR) Now Attractive After A 21% One Year Share Price Decline?

If you are wondering whether Bruker is priced attractively right now, you are not alone, especially with sentiment around the stock shifting recently. The share price closed at US$39.77, with a 4.3% gain over the last 7 days, set against returns of a 21.0% decline over 30 days, a 17.3% decline year to date, and a 21.6% decline over 1 year, as well as 41.7% and 35.1% declines over 3 and 5 years respectively. These mixed shorter term and longer term returns have put more attention on what...
NYSE:O
NYSE:ORetail REITs

Realty Income (O) Valuation Check After Recent Share Price Momentum And Spirit Merger Impact

Why Realty Income is on investors’ radar today Realty Income (O) is drawing fresh interest after recent share price moves, with the stock last closing at $66.52. For income focused investors, that prompts a closer look at its current profile. See our latest analysis for Realty Income. Recent moves fit into a stronger run, with a 30-day share price return of 9.52% and a 90-day share price return of 16.42%, while the 1-year total shareholder return of 25.07% points to building momentum around...
NasdaqGS:TENB
NasdaqGS:TENBSoftware

Tenable Holdings (TENB) Is Down 17.2% After Tariff Hike And AI Security Jitters - Has The Bull Case Changed?

Earlier this week, Tenable Holdings, a cybersecurity and vulnerability management provider, came under pressure after the White House announced plans to lift global tariffs to 15%, sparking renewed concern about trade policy and its knock-on effects for technology and software firms. At the same time, investors are weighing Tenable’s ongoing profitability and liquidity challenges against sector worries that rapid advances in artificial intelligence could reshape demand for traditional...
NasdaqCM:TGTX
NasdaqCM:TGTXBiotechs

Does TG Therapeutics (TGTX) Offer Value After Recent Share Price Swings

If you are wondering whether TG Therapeutics at around US$30.51 is priced attractively or already baking in a lot of optimism, you are in the right place. The stock has returned 5.0% over the last 7 days, is down 2.2% over 30 days, and shows mixed longer term results with a 4.2% return year to date, 4.5% over 1 year, 90.4% over 3 years, and a 32.0% decline over 5 years. These moves sit against a backdrop of ongoing interest in TG Therapeutics as a biotechnology name, with investors watching...